Skip to main content
. 2020 Jan 21;2020:7025738. doi: 10.1155/2020/7025738

Table 3.

One-way ANOVA result of CD4 cells among patients living with HIV/AIDS taking IPT and ART versus ART alone in Northern Ethiopia, 2009–2017.

Exposure to IPT Mean CD4 cells per cubic millimeter + SEM
Baseline Unexposed group (on ART alone) 177.75 ± 3.24
Exposed group (on IPT + ART) 194.14 ± 6.33
2009 Unexposed group (on ART alone) 186.12 ± 3.76
Exposed group (on IPT + ART) 215.18 ± 6.22∗∗
2010 Unexposed group (on ART alone) 261.38 ± 4.77
Exposed group (on IPT + ART) 306.7 ± 7.70
2011 Unexposed group (on ART alone) 354.33 ± 6.76
Exposed group (on IPT + ART) 385.69 ± 10.61
2012 Unexposed group (on ART alone) 392.67 ± 6.74
Exposed group (on IPT + ART) 412.66 ± 10.59
2013 Unexposed group (on ART alone) 442.15 ± 9.02
Exposed group (on IPT + ART) 457.16 ± 11.51
2014 Unexposed group (on ART alone) 473.91 ± 9.78
Exposed group (on IPT + ART) 498.38 ± 11.69
2015 Unexposed group (on ART alone) 479.97 ± 8.40
Exposed group (on IPT + ART) 528.92 ± 12.54∗∗
2016 Unexposed group (on ART alone) 522.13 ± 9.34
Exposed group (on IPT + ART) 536.84 ± 10.91
2017 Exposed group (on IPT + ART) 511.33 ± 9.00
Unexposed group (on ART alone) 538.94 ± 11.05

Statistically significant p value < 0.05; ∗∗statistically significant p value < 0.01. Effect of IPT on all-cause mortality and associated factors.